nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—mammary gland—breast cancer	0.0191	0.0696	CbGeAlD
Alendronate—ATP6V1A—mammary gland—breast cancer	0.00897	0.0327	CbGeAlD
Alendronate—PTPRE—adipose tissue—breast cancer	0.00859	0.0313	CbGeAlD
Alendronate—PTPN4—uterus—breast cancer	0.00835	0.0305	CbGeAlD
Alendronate—PTPN4—pituitary gland—breast cancer	0.0082	0.0299	CbGeAlD
Alendronate—PTPN4—adipose tissue—breast cancer	0.00817	0.0298	CbGeAlD
Alendronate—PTPRE—female reproductive system—breast cancer	0.0079	0.0288	CbGeAlD
Alendronate—PTPRE—adrenal gland—breast cancer	0.00771	0.0281	CbGeAlD
Alendronate—PTPN4—female reproductive system—breast cancer	0.00751	0.0274	CbGeAlD
Alendronate—PTPRE—bone marrow—breast cancer	0.00745	0.0272	CbGeAlD
Alendronate—ATP6V1A—nipple—breast cancer	0.00742	0.027	CbGeAlD
Alendronate—PTPN4—adrenal gland—breast cancer	0.00733	0.0267	CbGeAlD
Alendronate—PTPRE—female gonad—breast cancer	0.00718	0.0262	CbGeAlD
Alendronate—PTPN4—bone marrow—breast cancer	0.00709	0.0258	CbGeAlD
Alendronate—PTPRS—adipose tissue—breast cancer	0.007	0.0255	CbGeAlD
Alendronate—PTPN4—female gonad—breast cancer	0.00683	0.0249	CbGeAlD
Alendronate—PTPRE—endocrine gland—breast cancer	0.00668	0.0244	CbGeAlD
Alendronate—PTPRS—female reproductive system—breast cancer	0.00644	0.0235	CbGeAlD
Alendronate—PTPN4—endocrine gland—breast cancer	0.00636	0.0232	CbGeAlD
Alendronate—PTPRS—adrenal gland—breast cancer	0.00628	0.0229	CbGeAlD
Alendronate—ATP6V1A—embryo—breast cancer	0.00612	0.0223	CbGeAlD
Alendronate—PTPRS—bone marrow—breast cancer	0.00608	0.0221	CbGeAlD
Alendronate—PTPRS—female gonad—breast cancer	0.00586	0.0213	CbGeAlD
Alendronate—FDPS—nipple—breast cancer	0.00559	0.0204	CbGeAlD
Alendronate—PTPRS—endocrine gland—breast cancer	0.00545	0.0199	CbGeAlD
Alendronate—ATP6V1A—skin of body—breast cancer	0.00475	0.0173	CbGeAlD
Alendronate—PTPRE—lymph node—breast cancer	0.00462	0.0168	CbGeAlD
Alendronate—ATP6V1A—endometrium—breast cancer	0.00448	0.0163	CbGeAlD
Alendronate—PTPN4—lymph node—breast cancer	0.00439	0.016	CbGeAlD
Alendronate—ATP6V1A—uterus—breast cancer	0.00413	0.015	CbGeAlD
Alendronate—ATP6V1A—pituitary gland—breast cancer	0.00405	0.0148	CbGeAlD
Alendronate—ATP6V1A—adipose tissue—breast cancer	0.00404	0.0147	CbGeAlD
Alendronate—PTPRS—lymph node—breast cancer	0.00377	0.0137	CbGeAlD
Alendronate—ATP6V1A—female reproductive system—breast cancer	0.00371	0.0135	CbGeAlD
Alendronate—ATP6V1A—adrenal gland—breast cancer	0.00362	0.0132	CbGeAlD
Alendronate—FDPS—skin of body—breast cancer	0.00358	0.013	CbGeAlD
Alendronate—ATP6V1A—bone marrow—breast cancer	0.0035	0.0128	CbGeAlD
Alendronate—ATP6V1A—female gonad—breast cancer	0.00338	0.0123	CbGeAlD
Alendronate—FDPS—endometrium—breast cancer	0.00338	0.0123	CbGeAlD
Alendronate—ATP6V1A—endocrine gland—breast cancer	0.00314	0.0114	CbGeAlD
Alendronate—FDPS—uterus—breast cancer	0.00311	0.0113	CbGeAlD
Alendronate—Zoledronate—ABCC1—breast cancer	0.00309	0.433	CrCbGaD
Alendronate—FDPS—pituitary gland—breast cancer	0.00305	0.0111	CbGeAlD
Alendronate—FDPS—adipose tissue—breast cancer	0.00304	0.0111	CbGeAlD
Alendronate—FDPS—female reproductive system—breast cancer	0.0028	0.0102	CbGeAlD
Alendronate—FDPS—adrenal gland—breast cancer	0.00273	0.00995	CbGeAlD
Alendronate—FDPS—bone marrow—breast cancer	0.00264	0.00962	CbGeAlD
Alendronate—FDPS—female gonad—breast cancer	0.00254	0.00927	CbGeAlD
Alendronate—FDPS—endocrine gland—breast cancer	0.00237	0.00862	CbGeAlD
Alendronate—ATP6V1A—lymph node—breast cancer	0.00217	0.00791	CbGeAlD
Alendronate—FDPS—lymph node—breast cancer	0.00164	0.00596	CbGeAlD
Alendronate—Risedronate—PTGS2—breast cancer	0.00124	0.173	CrCbGaD
Alendronate—Clodronate—PTGS2—breast cancer	0.0011	0.154	CrCbGaD
Alendronate—Histamine Phosphate—CYP2D6—breast cancer	0.00092	0.129	CrCbGaD
Alendronate—Histamine Phosphate—CYP3A4—breast cancer	0.000789	0.11	CrCbGaD
Alendronate—Muscle spasms—Docetaxel—breast cancer	0.000267	0.000511	CcSEcCtD
Alendronate—Infection—Paclitaxel—breast cancer	0.000265	0.000509	CcSEcCtD
Alendronate—Flatulence—Capecitabine—breast cancer	0.000265	0.000507	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—breast cancer	0.000264	0.000505	CcSEcCtD
Alendronate—Nausea—Goserelin—breast cancer	0.000263	0.000505	CcSEcCtD
Alendronate—Dysgeusia—Capecitabine—breast cancer	0.000263	0.000504	CcSEcCtD
Alendronate—Feeling abnormal—Gemcitabine—breast cancer	0.000263	0.000504	CcSEcCtD
Alendronate—Dizziness—Vinorelbine—breast cancer	0.000263	0.000504	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—breast cancer	0.000262	0.000502	CcSEcCtD
Alendronate—Urticaria—Mitoxantrone—breast cancer	0.00026	0.000499	CcSEcCtD
Alendronate—Diarrhoea—Thiotepa—breast cancer	0.00026	0.000498	CcSEcCtD
Alendronate—Abdominal pain—Mitoxantrone—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Body temperature increased—Mitoxantrone—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Abdominal pain—Irinotecan—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Body temperature increased—Irinotecan—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Feeling abnormal—Fluorouracil—breast cancer	0.000259	0.000496	CcSEcCtD
Alendronate—Muscle spasms—Capecitabine—breast cancer	0.000258	0.000495	CcSEcCtD
Alendronate—Anaemia—Docetaxel—breast cancer	0.000257	0.000492	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—breast cancer	0.000255	0.000488	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000254	0.000486	CcSEcCtD
Alendronate—Vomiting—Vinorelbine—breast cancer	0.000253	0.000484	CcSEcCtD
Alendronate—Body temperature increased—Gemcitabine—breast cancer	0.000252	0.000484	CcSEcCtD
Alendronate—Dizziness—Thiotepa—breast cancer	0.000251	0.000481	CcSEcCtD
Alendronate—Rash—Vinorelbine—breast cancer	0.00025	0.00048	CcSEcCtD
Alendronate—Dermatitis—Vinorelbine—breast cancer	0.00025	0.00048	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—breast cancer	0.00025	0.00048	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—breast cancer	0.00025	0.000478	CcSEcCtD
Alendronate—Ill-defined disorder—Capecitabine—breast cancer	0.000249	0.000478	CcSEcCtD
Alendronate—Urticaria—Fluorouracil—breast cancer	0.000249	0.000478	CcSEcCtD
Alendronate—Headache—Vinorelbine—breast cancer	0.000249	0.000477	CcSEcCtD
Alendronate—Asthma—Doxorubicin—breast cancer	0.000249	0.000476	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—breast cancer	0.000249	0.000476	CcSEcCtD
Alendronate—Anaemia—Capecitabine—breast cancer	0.000248	0.000476	CcSEcCtD
Alendronate—Body temperature increased—Fluorouracil—breast cancer	0.000248	0.000475	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—breast cancer	0.000245	0.00047	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000243	0.000467	CcSEcCtD
Alendronate—Malaise—Capecitabine—breast cancer	0.000242	0.000464	CcSEcCtD
Alendronate—Vertigo—Capecitabine—breast cancer	0.000241	0.000463	CcSEcCtD
Alendronate—Hypersensitivity—Mitoxantrone—breast cancer	0.000241	0.000463	CcSEcCtD
Alendronate—Hypersensitivity—Irinotecan—breast cancer	0.000241	0.000463	CcSEcCtD
Alendronate—Vomiting—Thiotepa—breast cancer	0.000241	0.000462	CcSEcCtD
Alendronate—Rash—Thiotepa—breast cancer	0.000239	0.000459	CcSEcCtD
Alendronate—Dermatitis—Thiotepa—breast cancer	0.000239	0.000458	CcSEcCtD
Alendronate—Headache—Thiotepa—breast cancer	0.000238	0.000456	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000237	0.000455	CcSEcCtD
Alendronate—Myalgia—Docetaxel—breast cancer	0.000236	0.000453	CcSEcCtD
Alendronate—Chest pain—Docetaxel—breast cancer	0.000236	0.000453	CcSEcCtD
Alendronate—Nausea—Vinorelbine—breast cancer	0.000236	0.000452	CcSEcCtD
Alendronate—Dyspepsia—Paclitaxel—breast cancer	0.000235	0.000451	CcSEcCtD
Alendronate—Asthenia—Irinotecan—breast cancer	0.000235	0.000451	CcSEcCtD
Alendronate—Asthenia—Mitoxantrone—breast cancer	0.000235	0.000451	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—breast cancer	0.000233	0.000448	CcSEcCtD
Alendronate—Hypersensitivity—Fluorouracil—breast cancer	0.000231	0.000443	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—breast cancer	0.000231	0.000443	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—breast cancer	0.00023	0.00044	CcSEcCtD
Alendronate—Asthenia—Gemcitabine—breast cancer	0.000229	0.000439	CcSEcCtD
Alendronate—Chest pain—Capecitabine—breast cancer	0.000229	0.000438	CcSEcCtD
Alendronate—Myalgia—Capecitabine—breast cancer	0.000229	0.000438	CcSEcCtD
Alendronate—Pain—Paclitaxel—breast cancer	0.000229	0.000438	CcSEcCtD
Alendronate—Constipation—Paclitaxel—breast cancer	0.000229	0.000438	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—breast cancer	0.000227	0.000435	CcSEcCtD
Alendronate—Discomfort—Capecitabine—breast cancer	0.000226	0.000433	CcSEcCtD
Alendronate—Pruritus—Gemcitabine—breast cancer	0.000226	0.000433	CcSEcCtD
Alendronate—Nausea—Thiotepa—breast cancer	0.000225	0.000432	CcSEcCtD
Alendronate—Infection—Docetaxel—breast cancer	0.000225	0.000431	CcSEcCtD
Alendronate—Diarrhoea—Mitoxantrone—breast cancer	0.000224	0.00043	CcSEcCtD
Alendronate—Diarrhoea—Irinotecan—breast cancer	0.000224	0.00043	CcSEcCtD
Alendronate—Pruritus—Fluorouracil—breast cancer	0.000222	0.000426	CcSEcCtD
Alendronate—Feeling abnormal—Paclitaxel—breast cancer	0.00022	0.000422	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.00022	0.000421	CcSEcCtD
Alendronate—Gastrointestinal pain—Paclitaxel—breast cancer	0.000219	0.000419	CcSEcCtD
Alendronate—Diarrhoea—Gemcitabine—breast cancer	0.000218	0.000419	CcSEcCtD
Alendronate—Infection—Capecitabine—breast cancer	0.000218	0.000418	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—breast cancer	0.000217	0.000416	CcSEcCtD
Alendronate—Dizziness—Irinotecan—breast cancer	0.000217	0.000415	CcSEcCtD
Alendronate—Haemoglobin—Epirubicin—breast cancer	0.000216	0.000414	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—breast cancer	0.000216	0.000414	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—breast cancer	0.000215	0.000412	CcSEcCtD
Alendronate—Diarrhoea—Fluorouracil—breast cancer	0.000215	0.000412	CcSEcCtD
Alendronate—Urticaria—Paclitaxel—breast cancer	0.000212	0.000407	CcSEcCtD
Alendronate—Oedema peripheral—Epirubicin—breast cancer	0.000212	0.000406	CcSEcCtD
Alendronate—Body temperature increased—Paclitaxel—breast cancer	0.000211	0.000405	CcSEcCtD
Alendronate—Abdominal pain—Paclitaxel—breast cancer	0.000211	0.000405	CcSEcCtD
Alendronate—Vomiting—Mitoxantrone—breast cancer	0.000208	0.000399	CcSEcCtD
Alendronate—Vomiting—Irinotecan—breast cancer	0.000208	0.000399	CcSEcCtD
Alendronate—Dizziness—Fluorouracil—breast cancer	0.000208	0.000398	CcSEcCtD
Alendronate—Rash—Mitoxantrone—breast cancer	0.000207	0.000396	CcSEcCtD
Alendronate—Rash—Irinotecan—breast cancer	0.000207	0.000396	CcSEcCtD
Alendronate—Dermatitis—Mitoxantrone—breast cancer	0.000206	0.000396	CcSEcCtD
Alendronate—Dermatitis—Irinotecan—breast cancer	0.000206	0.000396	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000206	0.000396	CcSEcCtD
Alendronate—Headache—Irinotecan—breast cancer	0.000205	0.000393	CcSEcCtD
Alendronate—Headache—Mitoxantrone—breast cancer	0.000205	0.000393	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—breast cancer	0.000203	0.00039	CcSEcCtD
Alendronate—Alopecia—Methotrexate—breast cancer	0.000203	0.000389	CcSEcCtD
Alendronate—Vomiting—Gemcitabine—breast cancer	0.000203	0.000389	CcSEcCtD
Alendronate—Rash—Gemcitabine—breast cancer	0.000201	0.000386	CcSEcCtD
Alendronate—Dermatitis—Gemcitabine—breast cancer	0.000201	0.000385	CcSEcCtD
Alendronate—Erythema—Methotrexate—breast cancer	0.0002	0.000383	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—breast cancer	0.0002	0.000383	CcSEcCtD
Alendronate—Headache—Gemcitabine—breast cancer	0.0002	0.000383	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Capecitabine—breast cancer	0.0002	0.000383	CcSEcCtD
Alendronate—Vomiting—Fluorouracil—breast cancer	0.0002	0.000382	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—breast cancer	0.000199	0.000382	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—breast cancer	0.000199	0.000381	CcSEcCtD
Alendronate—Rash—Fluorouracil—breast cancer	0.000198	0.000379	CcSEcCtD
Alendronate—Dermatitis—Fluorouracil—breast cancer	0.000198	0.000379	CcSEcCtD
Alendronate—Hypersensitivity—Paclitaxel—breast cancer	0.000197	0.000377	CcSEcCtD
Alendronate—Headache—Fluorouracil—breast cancer	0.000197	0.000377	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—breast cancer	0.000196	0.000376	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—breast cancer	0.000196	0.000375	CcSEcCtD
Alendronate—Nausea—Irinotecan—breast cancer	0.000195	0.000373	CcSEcCtD
Alendronate—Nausea—Mitoxantrone—breast cancer	0.000195	0.000373	CcSEcCtD
Alendronate—Pain—Docetaxel—breast cancer	0.000194	0.000371	CcSEcCtD
Alendronate—Constipation—Docetaxel—breast cancer	0.000194	0.000371	CcSEcCtD
Alendronate—Dyspepsia—Capecitabine—breast cancer	0.000193	0.00037	CcSEcCtD
Alendronate—Asthenia—Paclitaxel—breast cancer	0.000192	0.000367	CcSEcCtD
Alendronate—Alopecia—Epirubicin—breast cancer	0.00019	0.000364	CcSEcCtD
Alendronate—Nausea—Gemcitabine—breast cancer	0.00019	0.000363	CcSEcCtD
Alendronate—Pruritus—Paclitaxel—breast cancer	0.000189	0.000362	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—breast cancer	0.000188	0.000361	CcSEcCtD
Alendronate—Constipation—Capecitabine—breast cancer	0.000188	0.000359	CcSEcCtD
Alendronate—Pain—Capecitabine—breast cancer	0.000188	0.000359	CcSEcCtD
Alendronate—Erythema—Epirubicin—breast cancer	0.000187	0.000359	CcSEcCtD
Alendronate—Feeling abnormal—Docetaxel—breast cancer	0.000187	0.000358	CcSEcCtD
Alendronate—Nausea—Fluorouracil—breast cancer	0.000186	0.000357	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—breast cancer	0.000186	0.000356	CcSEcCtD
Alendronate—Gastrointestinal pain—Docetaxel—breast cancer	0.000185	0.000355	CcSEcCtD
Alendronate—Anaemia—Methotrexate—breast cancer	0.000185	0.000354	CcSEcCtD
Alendronate—Flatulence—Epirubicin—breast cancer	0.000184	0.000354	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000184	0.000937	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RGS2—breast cancer	0.000184	0.000933	CbGpPWpGaD
Alendronate—Dysgeusia—Epirubicin—breast cancer	0.000183	0.000351	CcSEcCtD
Alendronate—Diarrhoea—Paclitaxel—breast cancer	0.000183	0.00035	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000182	0.000927	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA2—breast cancer	0.000182	0.000925	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX2—breast cancer	0.000182	0.000925	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL20—breast cancer	0.000182	0.000922	CbGpPWpGaD
Alendronate—Feeling abnormal—Capecitabine—breast cancer	0.000181	0.000346	CcSEcCtD
Alendronate—Malaise—Methotrexate—breast cancer	0.00018	0.000346	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—breast cancer	0.00018	0.000345	CcSEcCtD
Alendronate—Vertigo—Methotrexate—breast cancer	0.00018	0.000344	CcSEcCtD
Alendronate—FDPS—Metabolism—SULT1A1—breast cancer	0.00018	0.000913	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX4—breast cancer	0.00018	0.000913	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Capecitabine—breast cancer	0.000179	0.000344	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—breast cancer	0.000179	0.000343	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—breast cancer	0.000179	0.000343	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF3—breast cancer	0.000178	0.000905	CbGpPWpGaD
Alendronate—Dizziness—Paclitaxel—breast cancer	0.000177	0.000339	CcSEcCtD
Alendronate—ATP6V1A—Disease—FASN—breast cancer	0.000176	0.000894	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—JAG1—breast cancer	0.000176	0.000894	CbGpPWpGaD
Alendronate—Alopecia—Doxorubicin—breast cancer	0.000176	0.000337	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—LPAR1—breast cancer	0.000176	0.000893	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TLE3—breast cancer	0.000176	0.000893	CbGpPWpGaD
Alendronate—FDPS—Metabolism—IDH1—breast cancer	0.000176	0.000892	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA1—breast cancer	0.000176	0.000892	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PARP1—breast cancer	0.000175	0.00089	CbGpPWpGaD
Alendronate—Urticaria—Capecitabine—breast cancer	0.000174	0.000334	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HEY1—breast cancer	0.000174	0.000884	CbGpPWpGaD
Alendronate—Ill-defined disorder—Epirubicin—breast cancer	0.000174	0.000333	CcSEcCtD
Alendronate—FDPS—Metabolism—NAT2—breast cancer	0.000174	0.000882	CbGpPWpGaD
Alendronate—Body temperature increased—Capecitabine—breast cancer	0.000173	0.000332	CcSEcCtD
Alendronate—Abdominal pain—Capecitabine—breast cancer	0.000173	0.000332	CcSEcCtD
Alendronate—Erythema—Doxorubicin—breast cancer	0.000173	0.000332	CcSEcCtD
Alendronate—Anaemia—Epirubicin—breast cancer	0.000173	0.000332	CcSEcCtD
Alendronate—ATP6V1A—Disease—CALCA—breast cancer	0.000173	0.000879	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPS6—breast cancer	0.000171	0.000869	CbGpPWpGaD
Alendronate—Flatulence—Doxorubicin—breast cancer	0.000171	0.000327	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DLL1—breast cancer	0.000171	0.000867	CbGpPWpGaD
Alendronate—Myalgia—Methotrexate—breast cancer	0.00017	0.000326	CcSEcCtD
Alendronate—Chest pain—Methotrexate—breast cancer	0.00017	0.000326	CcSEcCtD
Alendronate—Vomiting—Paclitaxel—breast cancer	0.00017	0.000326	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—breast cancer	0.00017	0.000325	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF4—breast cancer	0.00017	0.000862	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CXCR4—breast cancer	0.000169	0.000859	CbGpPWpGaD
Alendronate—Malaise—Epirubicin—breast cancer	0.000169	0.000324	CcSEcCtD
Alendronate—Rash—Paclitaxel—breast cancer	0.000168	0.000323	CcSEcCtD
Alendronate—Dermatitis—Paclitaxel—breast cancer	0.000168	0.000323	CcSEcCtD
Alendronate—Discomfort—Methotrexate—breast cancer	0.000168	0.000322	CcSEcCtD
Alendronate—Vertigo—Epirubicin—breast cancer	0.000168	0.000322	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HIST1H2BK—breast cancer	0.000168	0.000851	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIST1H2BC—breast cancer	0.000168	0.000851	CbGpPWpGaD
Alendronate—Headache—Paclitaxel—breast cancer	0.000167	0.000321	CcSEcCtD
Alendronate—ATP6V1A—Disease—SLC2A1—breast cancer	0.000167	0.000849	CbGpPWpGaD
Alendronate—Hypersensitivity—Docetaxel—breast cancer	0.000167	0.00032	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—breast cancer	0.000167	0.000319	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GRB7—breast cancer	0.000166	0.000844	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDE4D—breast cancer	0.000166	0.000844	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TAB2—breast cancer	0.000163	0.000829	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TCF7L2—breast cancer	0.000163	0.000828	CbGpPWpGaD
Alendronate—Asthenia—Docetaxel—breast cancer	0.000163	0.000311	CcSEcCtD
Alendronate—Infection—Methotrexate—breast cancer	0.000162	0.000311	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CNR2—breast cancer	0.000162	0.000822	CbGpPWpGaD
Alendronate—Hypersensitivity—Capecitabine—breast cancer	0.000162	0.00031	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—breast cancer	0.000161	0.000308	CcSEcCtD
Alendronate—Pruritus—Docetaxel—breast cancer	0.00016	0.000307	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—breast cancer	0.00016	0.000307	CcSEcCtD
Alendronate—Myalgia—Epirubicin—breast cancer	0.000159	0.000305	CcSEcCtD
Alendronate—Chest pain—Epirubicin—breast cancer	0.000159	0.000305	CcSEcCtD
Alendronate—Nausea—Paclitaxel—breast cancer	0.000159	0.000304	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DKK1—breast cancer	0.000158	0.000803	CbGpPWpGaD
Alendronate—Discomfort—Epirubicin—breast cancer	0.000157	0.000302	CcSEcCtD
Alendronate—Asthenia—Capecitabine—breast cancer	0.000157	0.000302	CcSEcCtD
Alendronate—ATP6V1A—Disease—HSP90AA1—breast cancer	0.000157	0.000798	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000157	0.000797	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFC—breast cancer	0.000157	0.000796	CbGpPWpGaD
Alendronate—Malaise—Doxorubicin—breast cancer	0.000156	0.000299	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—breast cancer	0.000156	0.000298	CcSEcCtD
Alendronate—Pruritus—Capecitabine—breast cancer	0.000155	0.000297	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—breast cancer	0.000155	0.000297	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—JAG2—breast cancer	0.000154	0.000784	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRL—breast cancer	0.000153	0.000776	CbGpPWpGaD
Alendronate—FDPS—Metabolism—DPYD—breast cancer	0.000152	0.000773	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MED12—breast cancer	0.000152	0.000773	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—WNT1—breast cancer	0.000152	0.000773	CbGpPWpGaD
Alendronate—Infection—Epirubicin—breast cancer	0.000152	0.000291	CcSEcCtD
Alendronate—ATP6V1A—Disease—ADAM10—breast cancer	0.000151	0.000765	CbGpPWpGaD
Alendronate—Diarrhoea—Capecitabine—breast cancer	0.00015	0.000288	CcSEcCtD
Alendronate—FDPS—Metabolism—ALDOA—breast cancer	0.00015	0.000761	CbGpPWpGaD
Alendronate—Dizziness—Docetaxel—breast cancer	0.00015	0.000287	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000149	0.000285	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—breast cancer	0.000148	0.00075	CbGpPWpGaD
Alendronate—Myalgia—Doxorubicin—breast cancer	0.000147	0.000283	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—breast cancer	0.000147	0.000283	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF10—breast cancer	0.000146	0.000744	CbGpPWpGaD
Alendronate—Discomfort—Doxorubicin—breast cancer	0.000146	0.000279	CcSEcCtD
Alendronate—FDPS—Metabolism—NCOA3—breast cancer	0.000145	0.000739	CbGpPWpGaD
Alendronate—Dizziness—Capecitabine—breast cancer	0.000145	0.000278	CcSEcCtD
Alendronate—FDPS—Metabolism—SLC2A2—breast cancer	0.000144	0.000734	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH4—breast cancer	0.000144	0.000733	CbGpPWpGaD
Alendronate—Vomiting—Docetaxel—breast cancer	0.000144	0.000276	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—breast cancer	0.000144	0.000275	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GZMB—breast cancer	0.000143	0.000728	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000143	0.000726	CbGpPWpGaD
Alendronate—Rash—Docetaxel—breast cancer	0.000143	0.000274	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—breast cancer	0.000143	0.000273	CcSEcCtD
Alendronate—Headache—Docetaxel—breast cancer	0.000142	0.000272	CcSEcCtD
Alendronate—FDPS—Metabolism—CPT1A—breast cancer	0.000141	0.000719	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTR—breast cancer	0.000141	0.000719	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG2—breast cancer	0.000141	0.000719	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFA—breast cancer	0.000141	0.000718	CbGpPWpGaD
Alendronate—Infection—Doxorubicin—breast cancer	0.00014	0.000269	CcSEcCtD
Alendronate—Pain—Methotrexate—breast cancer	0.00014	0.000268	CcSEcCtD
Alendronate—Vomiting—Capecitabine—breast cancer	0.000139	0.000267	CcSEcCtD
Alendronate—ATP6V1A—Disease—TGFBR2—breast cancer	0.000139	0.000708	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000139	0.000267	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CXCL2—breast cancer	0.000139	0.000707	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR2—breast cancer	0.000139	0.000707	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HPGDS—breast cancer	0.000139	0.000705	CbGpPWpGaD
Alendronate—Rash—Capecitabine—breast cancer	0.000138	0.000265	CcSEcCtD
Alendronate—Dermatitis—Capecitabine—breast cancer	0.000138	0.000265	CcSEcCtD
Alendronate—FDPS—Metabolism—HBA1—breast cancer	0.000138	0.000701	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—breast cancer	0.000138	0.000699	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BMP2—breast cancer	0.000138	0.000699	CbGpPWpGaD
Alendronate—Headache—Capecitabine—breast cancer	0.000137	0.000263	CcSEcCtD
Alendronate—ATP6V1A—Disease—ITPR1—breast cancer	0.000137	0.000697	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB4—breast cancer	0.000136	0.000692	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT5A—breast cancer	0.000136	0.000692	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACHE—breast cancer	0.000135	0.000684	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTT1—breast cancer	0.000135	0.000684	CbGpPWpGaD
Alendronate—Nausea—Docetaxel—breast cancer	0.000135	0.000258	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—breast cancer	0.000135	0.000258	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—breast cancer	0.000134	0.000258	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—breast cancer	0.000133	0.000256	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—RAF1—breast cancer	0.000133	0.000678	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDNRB—breast cancer	0.000133	0.000677	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PGR—breast cancer	0.000132	0.00067	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMAD4—breast cancer	0.000132	0.00067	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—THBS1—breast cancer	0.000131	0.000667	CbGpPWpGaD
Alendronate—Constipation—Epirubicin—breast cancer	0.000131	0.00025	CcSEcCtD
Alendronate—Pain—Epirubicin—breast cancer	0.000131	0.00025	CcSEcCtD
Alendronate—Nausea—Capecitabine—breast cancer	0.00013	0.00025	CcSEcCtD
Alendronate—Urticaria—Methotrexate—breast cancer	0.00013	0.000249	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—breast cancer	0.000129	0.000247	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—breast cancer	0.000129	0.000247	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000129	0.000247	CcSEcCtD
Alendronate—ATP6V1A—Disease—HES1—breast cancer	0.000129	0.000654	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NCOR1—breast cancer	0.000128	0.000651	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP17A1—breast cancer	0.000127	0.000647	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF1—breast cancer	0.000127	0.000643	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO1—breast cancer	0.000126	0.000641	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS1—breast cancer	0.000126	0.000641	CbGpPWpGaD
Alendronate—Feeling abnormal—Epirubicin—breast cancer	0.000126	0.000241	CcSEcCtD
Alendronate—ATP6V1A—Disease—NRG1—breast cancer	0.000126	0.000639	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000126	0.000638	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FLT1—breast cancer	0.000125	0.000637	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Epirubicin—breast cancer	0.000125	0.000239	CcSEcCtD
Alendronate—ATP6V1A—Disease—H2AFX—breast cancer	0.000125	0.000634	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF3—breast cancer	0.000125	0.000634	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SQSTM1—breast cancer	0.000125	0.000634	CbGpPWpGaD
Alendronate—Dyspepsia—Doxorubicin—breast cancer	0.000124	0.000239	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000124	0.00063	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2D6—breast cancer	0.000124	0.000628	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAG1—breast cancer	0.000123	0.000626	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PARP1—breast cancer	0.000123	0.000623	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH3—breast cancer	0.000123	0.000623	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA2—breast cancer	0.000121	0.000617	CbGpPWpGaD
Alendronate—Urticaria—Epirubicin—breast cancer	0.000121	0.000233	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CALCA—breast cancer	0.000121	0.000616	CbGpPWpGaD
Alendronate—Constipation—Doxorubicin—breast cancer	0.000121	0.000232	CcSEcCtD
Alendronate—Pain—Doxorubicin—breast cancer	0.000121	0.000232	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—breast cancer	0.000121	0.000231	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—breast cancer	0.000121	0.000231	CcSEcCtD
Alendronate—ATP6V1A—Disease—ERCC2—breast cancer	0.00012	0.000612	CbGpPWpGaD
Alendronate—Hypersensitivity—Methotrexate—breast cancer	0.00012	0.000231	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—RPS6—breast cancer	0.00012	0.000608	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF4—breast cancer	0.000119	0.000603	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL12—breast cancer	0.000118	0.000601	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCR4—breast cancer	0.000118	0.000601	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB3—breast cancer	0.000118	0.000598	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FASN—breast cancer	0.000118	0.000598	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGFR2—breast cancer	0.000118	0.000597	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BCHE—breast cancer	0.000117	0.000596	CbGpPWpGaD
Alendronate—Asthenia—Methotrexate—breast cancer	0.000117	0.000225	CcSEcCtD
Alendronate—Feeling abnormal—Doxorubicin—breast cancer	0.000116	0.000223	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PAK1—breast cancer	0.000116	0.00059	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC5A5—breast cancer	0.000116	0.000588	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Doxorubicin—breast cancer	0.000116	0.000222	CcSEcCtD
Alendronate—Pruritus—Methotrexate—breast cancer	0.000115	0.000221	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—TCF7L2—breast cancer	0.000114	0.00058	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—breast cancer	0.000113	0.000575	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TERT—breast cancer	0.000113	0.000573	CbGpPWpGaD
Alendronate—Hypersensitivity—Epirubicin—breast cancer	0.000113	0.000216	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—breast cancer	0.000112	0.000215	CcSEcCtD
Alendronate—FDPS—Metabolism—NQO1—breast cancer	0.000112	0.000568	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A1—breast cancer	0.000112	0.000568	CbGpPWpGaD
Alendronate—Abdominal pain—Doxorubicin—breast cancer	0.000112	0.000214	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—breast cancer	0.000112	0.000214	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—breast cancer	0.000112	0.000214	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HSP90AA1—breast cancer	0.00011	0.000559	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH2—breast cancer	0.00011	0.000559	CbGpPWpGaD
Alendronate—Asthenia—Epirubicin—breast cancer	0.00011	0.00021	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGFR1—breast cancer	0.00011	0.000557	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.00011	0.000557	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP3A4—breast cancer	0.000109	0.000554	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000109	0.000551	CbGpPWpGaD
Alendronate—Pruritus—Epirubicin—breast cancer	0.000108	0.000207	CcSEcCtD
Alendronate—Dizziness—Methotrexate—breast cancer	0.000108	0.000207	CcSEcCtD
Alendronate—ATP6V1A—Disease—HIF1A—breast cancer	0.000108	0.000548	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1B1—breast cancer	0.000107	0.000545	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR1—breast cancer	0.000107	0.000544	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRL—breast cancer	0.000107	0.000544	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STK11—breast cancer	0.000105	0.000536	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADAM10—breast cancer	0.000105	0.000536	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSP90AA1—breast cancer	0.000105	0.000534	CbGpPWpGaD
Alendronate—Diarrhoea—Epirubicin—breast cancer	0.000105	0.0002	CcSEcCtD
Alendronate—ATP6V1A—Disease—CAV1—breast cancer	0.000104	0.00053	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLG—breast cancer	0.000104	0.00053	CbGpPWpGaD
Alendronate—Hypersensitivity—Doxorubicin—breast cancer	0.000104	0.0002	CcSEcCtD
Alendronate—Vomiting—Methotrexate—breast cancer	0.000104	0.000199	CcSEcCtD
Alendronate—Rash—Methotrexate—breast cancer	0.000103	0.000197	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—breast cancer	0.000103	0.000197	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGF10—breast cancer	0.000103	0.000521	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA1—breast cancer	0.000102	0.00052	CbGpPWpGaD
Alendronate—Headache—Methotrexate—breast cancer	0.000102	0.000196	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—breast cancer	0.000101	0.000194	CcSEcCtD
Alendronate—Dizziness—Epirubicin—breast cancer	0.000101	0.000194	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP19A1—breast cancer	0.000101	0.000512	CbGpPWpGaD
Alendronate—FDPS—Metabolism—STK11—breast cancer	0.000101	0.000512	CbGpPWpGaD
Alendronate—Pruritus—Doxorubicin—breast cancer	0.0001	0.000192	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PDGFA—breast cancer	9.9e-05	0.000503	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—breast cancer	9.82e-05	0.000499	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFBR2—breast cancer	9.76e-05	0.000496	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOTCH1—breast cancer	9.72e-05	0.000494	CbGpPWpGaD
Alendronate—Vomiting—Epirubicin—breast cancer	9.71e-05	0.000186	CcSEcCtD
Alendronate—Nausea—Methotrexate—breast cancer	9.7e-05	0.000186	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—breast cancer	9.67e-05	0.000185	CcSEcCtD
Alendronate—Rash—Epirubicin—breast cancer	9.63e-05	0.000185	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—breast cancer	9.62e-05	0.000184	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ITPR1—breast cancer	9.6e-05	0.000488	CbGpPWpGaD
Alendronate—Headache—Epirubicin—breast cancer	9.57e-05	0.000183	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ERBB4—breast cancer	9.54e-05	0.000485	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT5A—breast cancer	9.54e-05	0.000485	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP3—breast cancer	9.54e-05	0.000485	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APC—breast cancer	9.51e-05	0.000483	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KIT—breast cancer	9.51e-05	0.000483	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.46e-05	0.000481	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGF—breast cancer	9.4e-05	0.000478	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COMT—breast cancer	9.37e-05	0.000476	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—breast cancer	9.35e-05	0.000179	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTP1—breast cancer	9.33e-05	0.000474	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SMAD4—breast cancer	9.23e-05	0.000469	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—breast cancer	9.2e-05	0.000467	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—breast cancer	9.18e-05	0.000466	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ITPR1—breast cancer	9.18e-05	0.000466	CbGpPWpGaD
Alendronate—Nausea—Epirubicin—breast cancer	9.07e-05	0.000174	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HES1—breast cancer	9.02e-05	0.000458	CbGpPWpGaD
Alendronate—Vomiting—Doxorubicin—breast cancer	8.99e-05	0.000172	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—NCOR1—breast cancer	8.96e-05	0.000456	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLA2G4A—breast cancer	8.96e-05	0.000456	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BRAF—breast cancer	8.94e-05	0.000454	CbGpPWpGaD
Alendronate—Rash—Doxorubicin—breast cancer	8.91e-05	0.000171	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—breast cancer	8.9e-05	0.000171	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGF1—breast cancer	8.86e-05	0.000451	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CSF2—breast cancer	8.86e-05	0.000451	CbGpPWpGaD
Alendronate—Headache—Doxorubicin—breast cancer	8.86e-05	0.00017	CcSEcCtD
Alendronate—FDPS—Metabolism—ABCB1—breast cancer	8.83e-05	0.000449	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRG1—breast cancer	8.8e-05	0.000447	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—H2AFX—breast cancer	8.74e-05	0.000444	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT2—breast cancer	8.7e-05	0.000442	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—E2F1—breast cancer	8.67e-05	0.000441	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMS—breast cancer	8.67e-05	0.000441	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOR1—breast cancer	8.57e-05	0.000436	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLA2G4A—breast cancer	8.57e-05	0.000436	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—breast cancer	8.57e-05	0.000436	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—breast cancer	8.4e-05	0.000161	CcSEcCtD
Alendronate—ATP6V1A—Disease—PIK3CD—breast cancer	8.36e-05	0.000425	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SPP1—breast cancer	8.33e-05	0.000424	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—breast cancer	8.27e-05	0.00042	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB3—breast cancer	8.24e-05	0.000419	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR2—breast cancer	8.23e-05	0.000418	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—breast cancer	8.21e-05	0.000417	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A1—breast cancer	8.13e-05	0.000413	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ERCC2—breast cancer	8.06e-05	0.00041	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TERT—breast cancer	7.9e-05	0.000402	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—breast cancer	7.89e-05	0.000401	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR1—breast cancer	7.67e-05	0.00039	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—breast cancer	7.57e-05	0.000385	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIF1A—breast cancer	7.56e-05	0.000384	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MDM2—breast cancer	7.49e-05	0.00038	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RAF1—breast cancer	7.46e-05	0.000379	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB2—breast cancer	7.38e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—breast cancer	7.38e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CAV1—breast cancer	7.31e-05	0.000371	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CB—breast cancer	7.28e-05	0.00037	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTOR—breast cancer	7.28e-05	0.00037	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD4—breast cancer	7.27e-05	0.000369	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—breast cancer	7.23e-05	0.000367	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—breast cancer	7.22e-05	0.000367	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—breast cancer	7.04e-05	0.000358	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAV1—breast cancer	6.99e-05	0.000355	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FN1—breast cancer	6.96e-05	0.000354	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKBIA—breast cancer	6.87e-05	0.000349	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1B—breast cancer	6.84e-05	0.000347	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH1—breast cancer	6.81e-05	0.000346	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.68e-05	0.000339	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KIT—breast cancer	6.66e-05	0.000338	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—breast cancer	6.66e-05	0.000338	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APC—breast cancer	6.66e-05	0.000338	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGF—breast cancer	6.58e-05	0.000334	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CTNNB1—breast cancer	6.46e-05	0.000328	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CG—breast cancer	6.36e-05	0.000323	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1A—breast cancer	6.31e-05	0.000321	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTEN—breast cancer	6.29e-05	0.00032	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BRAF—breast cancer	6.26e-05	0.000318	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—breast cancer	6.09e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT2—breast cancer	6.09e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CD—breast cancer	5.85e-05	0.000297	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—breast cancer	5.84e-05	0.000297	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—breast cancer	5.79e-05	0.000294	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—breast cancer	5.63e-05	0.000286	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CD—breast cancer	5.59e-05	0.000284	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—breast cancer	5.53e-05	0.000281	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—breast cancer	5.52e-05	0.000281	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK3—breast cancer	5.38e-05	0.000273	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—breast cancer	5.28e-05	0.000269	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MDM2—breast cancer	5.24e-05	0.000266	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—breast cancer	5.23e-05	0.000266	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RAF1—breast cancer	5.22e-05	0.000266	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—breast cancer	5.22e-05	0.000265	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RELA—breast cancer	5.2e-05	0.000264	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB2—breast cancer	5.17e-05	0.000263	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—breast cancer	5.12e-05	0.00026	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTOR—breast cancer	5.1e-05	0.000259	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CB—breast cancer	5.1e-05	0.000259	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—breast cancer	4.9e-05	0.000249	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CB—breast cancer	4.88e-05	0.000248	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—breast cancer	4.83e-05	0.000246	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—breast cancer	4.83e-05	0.000246	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1B—breast cancer	4.79e-05	0.000243	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—breast cancer	4.69e-05	0.000238	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL2—breast cancer	4.68e-05	0.000238	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—breast cancer	4.57e-05	0.000232	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—breast cancer	4.56e-05	0.000232	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CTNNB1—breast cancer	4.52e-05	0.00023	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—breast cancer	4.44e-05	0.000226	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—breast cancer	4.43e-05	0.000225	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1A—breast cancer	4.42e-05	0.000225	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTEN—breast cancer	4.41e-05	0.000224	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—breast cancer	4.31e-05	0.000219	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTEN—breast cancer	4.21e-05	0.000214	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—breast cancer	4.11e-05	0.000209	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—breast cancer	4.09e-05	0.000208	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—breast cancer	3.98e-05	0.000202	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—breast cancer	3.94e-05	0.0002	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—breast cancer	3.93e-05	0.0002	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK3—breast cancer	3.77e-05	0.000191	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—breast cancer	3.66e-05	0.000186	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—breast cancer	3.65e-05	0.000186	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—breast cancer	3.63e-05	0.000184	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—breast cancer	3.58e-05	0.000182	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—breast cancer	3.38e-05	0.000172	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—breast cancer	3.11e-05	0.000158	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—breast cancer	3.01e-05	0.000153	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—breast cancer	2.97e-05	0.000151	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—breast cancer	2.88e-05	0.000146	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—breast cancer	2.75e-05	0.00014	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—breast cancer	2.54e-05	0.000129	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—breast cancer	2.43e-05	0.000123	CbGpPWpGaD
